Clinic
Columbia Rio Grande Healthcare, L.P.
Columbia Rio Grande Healthcare, L.P. was paid $17.68M by Medicaid between May 2019 and Dec 2024, across 135 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoCOLUMBIA RIO GRANDE HEALTHCARE, L.P.
MCALLEN, TX 78503
MCALLEN, TX 78503
33aNPI1619924719assigned 05/27/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$17.68M
24GClaims337,145
24DCodes billed135
24AFirst – last monthMay 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#25 of 320
Median peer was paid$205K
This provider vs. median86×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 306 | $6K | |
| 2020 | 11,779 | $478K | |
| 2021 | 60,864 | $3.28M | |
| 2022 | 94,972 | $4.87M | |
| 2023 | 102,608 | $5.60M | |
| 2024incomplete | 66,616 | $3.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 48,923 | 47,886 | $6.83M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 21,682 | 20,689 | $4.85M |
| 41899 | Unlisted procedure, dentoalveolar structures | 6.7% | 1,027 | 998 | $1.19M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 4,816 | 4,736 | $625K |
| 80053 | Comprehensive metabolic panel | 2.8% | 16,511 | 15,472 | $502K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 2.4% | 844 | 790 | $425K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 11,147 | 10,874 | $265K |
| G0378 | Hospital observation service, per hour | 1.2% | 267 | 238 | $216K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 7,739 | 6,985 | $210K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 10,437 | 9,489 | $204K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 1,680 | 1,537 | $163K |
| 85027 | <1% | 32,977 | 30,252 | $151K |
123 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,271 | $148K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 162 | $135K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 750 | $93K |
| 87430 | <1% | 4,652 | $88K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,514 | $87K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,555 | $82K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,024 | $77K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,505 | $66K |
| 81003 | <1% | 11,019 | $61K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,093 | $61K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,871 | $60K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,535 | $56K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,501 | $56K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,998 | $54K |
| 80061 | Lipid panel | <1% | 3,638 | $51K |
| 59025 | Fetal non-stress test | <1% | 2,258 | $48K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,198 | $48K |
| 76801 | <1% | 508 | $46K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 9,883 | $42K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,084 | $40K |
| 81002 | <1% | 9,656 | $37K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 863 | $36K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,810 | $35K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 450 | $32K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 101 | $32K |
| 74018 | <1% | 328 | $25K | |
| 86703 | <1% | 2,217 | $24K | |
| 81025 | <1% | 3,525 | $23K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,580 | $21K |
| 84702 | <1% | 1,823 | $21K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,561 | $20K |
| 83525 | <1% | 1,892 | $20K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 993 | $19K |
| 87088 | <1% | 2,099 | $18K | |
| 86738 | <1% | 1,051 | $18K | |
| 81001 | <1% | 4,313 | $16K | |
| 86780 | <1% | 1,523 | $16K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 114 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 739 | $14K |
| 80076 | <1% | 3,001 | $14K | |
| 83690 | <1% | 4,306 | $10K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 303 | $10K |
| 84484 | <1% | 4,163 | $9K | |
| 87070 | <1% | 686 | $9K | |
| 84436 | <1% | 1,073 | $8K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 57 | $8K |
| 84479 | <1% | 953 | $8K | |
| 86756 | <1% | 281 | $8K | |
| 87662 | <1% | 268 | $8K | |
| 86885 | <1% | 1,309 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,175 | $6K |
| 83605 | <1% | 1,960 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 451 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,318 | $6K |
| 86696 | <1% | 314 | $6K | |
| 84481 | <1% | 612 | $6K | |
| 84439 | <1% | 805 | $5K | |
| 87807 | <1% | 776 | $5K | |
| 86762 | <1% | 423 | $5K | |
| 73610 | <1% | 28 | $5K | |
| 73030 | <1% | 41 | $4K | |
| 87340 | <1% | 629 | $4K | |
| 83880 | <1% | 1,163 | $4K | |
| 87040 | <1% | 1,533 | $4K | |
| 86900 | <1% | 1,792 | $4K | |
| 87507 | <1% | 93 | $4K | |
| 86695 | <1% | 314 | $4K | |
| 87077 | <1% | 593 | $3K | |
| 86901 | <1% | 1,793 | $3K | |
| 85730 | <1% | 2,632 | $3K | |
| 85610 | <1% | 2,919 | $3K | |
| 87634 | <1% | 70 | $3K | |
| J3490 | Unclassified drugs | <1% | 77 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 484 | $2K |
| 82950 | <1% | 593 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 268 | $2K |
| 73562 | <1% | 46 | $2K | |
| 82248 | <1% | 1,317 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,672 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 169 | $1K |
| 87186 | <1% | 452 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 879 | $1K |
| 73630 | <1% | 28 | $1K | |
| 86769 | <1% | 48 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,065 | $977.66 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,977 | $947.06 |
| 83735 | <1% | 950 | $935.84 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 28 | $883.44 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,141 | $876.69 |
| C1769 | Guide wire | <1% | 55 | $852.94 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 270 | $805.63 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,074 | $793.19 |
| 82150 | <1% | 480 | $744.95 | |
| J2704 | Injection, propofol, 10 mg | <1% | 494 | $635.29 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 776 | $564.77 |
| 82947 | <1% | 164 | $548.71 | |
| 87045 | <1% | 13 | $403.60 | |
| C1729 | Catheter, drainage | <1% | 15 | $372.90 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,065 | $263.43 |
| 82805 | <1% | 43 | $254.63 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 135 | $169.79 |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,196 | $167.10 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 647 | $123.49 |
| 82550 | <1% | 43 | $88.02 | |
| 84100 | <1% | 108 | $76.88 | |
| 85378 | <1% | 18 | $53.06 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 907 | $52.50 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 92 | $49.24 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 173 | $49.05 |
| 80320 | <1% | 13 | $28.26 | |
| 85652 | <1% | 12 | $8.76 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 28 | $5.68 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 401 | $0.75 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 487 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 32 | $0.00 |
| 88312 | 0% | 26 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 16 | $0.00 |
| A9270 | Non-covered item or service | 0% | 2,473 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 13 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 60 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 53 | $0.00 |
| 84132 | 0% | 12 | $0.00 | |
| 88342 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVELA, JOE (CFO)